OGN

Handel nachbörslich: 13.72 0.010 +0.07%

Organon Co (OGN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Organon Co Stock (OGN) Company Profile

Healthcare (1068)

551-430-6000

30 HUDSON STREET, JERSEY CITY

Nächster Verdiensttermin

Neueste SEC-Einreichungen

OGN's Discussions on Twitter

Compare OGN vs LLY, JNJ, ABBV, MRK, NVS

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
OGN Organon Co	13.71	3.61B	6.16B	246.00M	708.00M	0.9387
LLY Lilly Eli Co	1,149.85	1.05T	72.25B	25.28B	10.37B	27.78
JNJ Johnson Johnson	258.66	653.61B	97.93B	21.04B	17.80B	8.6278
ABBV Abbvie Inc	259.93	467.12B	62.82B	3.60B	19.98B	2.0274
MRK Merck Co Inc	143.81	367.07B	65.51B	8.93B	14.12B	3.5532
NVS Novartis Ag Adr	141.05	276.48B	54.66B	13.58B	16.05B	7.0171

Organon Co Stock (OGN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-09	Eingeleitet	Barclays	Underweight
2025-10-27	Herabstufung	Piper Sandler	Overweight → Underweight
2025-05-02	Herabstufung	Evercore ISI	Outperform → In-line
2024-09-06	Herabstufung	JP Morgan	Neutral → Underweight
2023-11-03	Herabstufung	Goldman	Buy → Neutral
2023-09-21	Eingeleitet	Barclays	Overweight
2023-03-16	Eingeleitet	Raymond James	Outperform
2022-10-14	Herabstufung	BofA Securities	Neutral → Underperform
2022-09-06	Hochstufung	Piper Sandler	Neutral → Overweight
2022-08-05	Herabstufung	BofA Securities	Buy → Neutral
2022-04-27	Eingeleitet	Goldman	Buy
2022-04-06	Fortgesetzt	Morgan Stanley	Equal-Weight
2021-10-07	Eingeleitet	Piper Sandler	Neutral
2021-09-01	Eingeleitet	BofA Securities	Buy
2021-07-22	Eingeleitet	Citigroup	Buy
2021-06-15	Eingeleitet	JP Morgan	Neutral
2021-06-11	Eingeleitet	Morgan Stanley	Equal-Weight
2021-06-10	Eingeleitet	Evercore ISI	Outperform

Alle ansehen

Organon Co Aktie (OGN) Neueste Nachrichten

Finanzdaten der Organon Co-Aktie (OGN)

Organon Co (OGN)

Organon Co Stock (OGN) Company Profile

Compare OGN vs LLY, JNJ, ABBV, MRK, NVS

Organon Co Stock (OGN) Upgrades & Downgrades

Organon Co Aktie (OGN) Neueste Nachrichten

Organon presents VTAMA analysis: Organon stock gains 1.16 percent - AD HOC NEWS

Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%, at the 2026 Fall Clinical Dermatology Conference - Business Wire

Organon & Co. (OGN) Stock Forecasts - Yahoo Finance

Tangible book value per share of Organon & Co. – HAN:7XP - TradingView

Organon & Co. Revenue Breakdown – HAN:7XP - TradingView

Sun Pharma plans $1 billion local debt sale for loan takeout, sources say - ETPharma.com

Sun Pharma Plans Rs 10,000 Crore Rupee Debt Sale To Refinance Organon Deal: Report - NDTV Profit

Sun Pharma plans $1 billion rupee debt sale to refinance Organon acquisition loan - Firstpost

Organon Says Nduvra Cream Gets Canada Approval for Atopic Dermatitis - marketscreener.com

Sun Pharma’s Biggest Global Bet, Buys Organon in $11.75 Billion Deal; Pharma Stock Surge 7%Time to Buy? - goodreturns.in

Organon & Co. (OGN) Stock forecasts - Yahoo Finance Singapore

Precision Trading with Organon & Co. (OGN) Risk Zones - Stock Traders Daily

Why Organon (OGN) Is Getting Attention Today - Yahoo Finance

Organon (OGN) Wins FDA Review Acceptance For Its Hormone Free Contraceptive Device - Yahoo Finance

Is Trending Stock Organon & Co. (OGN) a Buy Now? - Yahoo Finance

Organon (OGN) Looks 22% Overvalued Following The MIUDELLA FDA Filing - simplywall.st

Class A Dig — Organon/Sun Pharma premature-close (May ACQ deleted; early-2027 expected) - app.dealroom.co

Organon (OGN) Wins FDA Review Acceptance For New Hormone Free Contraceptive - simplywall.st

how InvestingPro spotted Organon’s 65% gain in healthcare sector By Investing.com - Investing.com Canada

Organon Backs Women’s Health Efforts Across India - pharmacy.biz

Organon Korea, Boryung expand Atozet tie-up to co-promotion - koreabiomed.com

Organon & Co. Common Stock (NY: OGN - The Chronicle-Journal

ORGANON & CO.MIUDELLA ANTICIPATED TO BE COMMERCIALLY AVAILABLE IN LATE 2026 - Moomoo

Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA - Business Wire

Responsive Playbooks and the OGN Inflection - Stock Traders Daily

Organon: A Merger-Arbitrage Hold With Limited Upside - Seeking Alpha

OGN Stock Set For Blastoff? Sun Pharma Offers 24% Premium In All-Cash Buyout Deal - Stocktwits

Sun Pharma Gets Investment-Grade Ratings From Moody's, S&P for USD 11.75 Bn Organon Deal - Medical Dialogues

Sun Pharma gets ratings boost from Moody's, S&P over $11.75-bn Organon bid - Business Standard

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Sun Pharma receives ratings boost over USD 11.75-billion Organon acqui - Daily Pioneer

Sun Pharma Gets Ratings Boost From Moody's, S&P Over $11.75-Bn Organon & Co Acquisition Bid - outlookbusiness.com

Sun Pharma gets ratings boost from Moody's, S&P over ₹11.75-billion Organon & Co acquisition bid - BusinessLine

Sun Pharma gets ratings boost from Moody's, S&P over $11.75 bn Organon & Co acquisition bid - ET Manufacturing

Sun Pharma gets ratings boost from Moody's, S&P over USD 11.75-bn Organon & Co acquisition bid - The Economic Times

Sun Pharma Gets Ratings Boost After Organon Acquisition Bid - Rediff MoneyWiz

Organon & Co. (OGN) Edges Up 0.15% to $13.78 as Shares Trade Between Key Support and ResistanceExtension Target - careplusvn.com

Organon & Co stock hits 52-week high at $13.78 By Investing.com - Investing.com Nigeria

Organon & Co stock hits 52-week high at $13.78 - Investing.com India

Henlius - henlius.com

Organon earnings up next: Can drugmaker rebound after Q1 miss? - investing.com

Organon (OGN) Move: Ends Up by 0.07% at $13.74 on the Day; Technical Setup: the $13.05 to $14.43 Range Remains in FocusBox Spread - Vinanet

Sun Pharma completes $11.75bn financing syndication for Organon acquisition - Generics and Biosimilars Initiative

Organon (OGN) Trading: Ends Up by 0.37% at $13.73 at the Close; Next Session: the Supplied Trading Band Runs From $13.04 to $14.42 under the Current SnapshotOvernight Profile - Vinanet

Organon & Co stock hits 52-week high at 13.73 USD - Investing.com

Organon & Co. (NYSE:OGN) Reaches New 12-Month HighStill a Buy? - MarketBeat

Orographic Financial Advisors, LLC's Organon & Co(OGN) Holding History - GuruFocus

how InvestingPro’s Fair Value spotted Organon’s 69% gain potential By Investing.com - Investing.com South Africa

Finanzdaten der Organon Co-Aktie (OGN)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie OGN